Erste Asset Management Gmb H Karuna Therapeutics, Inc. Transaction History

Erste Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 26, 2024	SELL	$0.0 - $329.83 $0 - $4.77 Million	-14,470 Closed	0 $0
Q4 2023 Nov 26, 2024	BUY	$161.01 - $317.85 $805,050 - $1.59 Million	5,000 Added 52.8%	14,470 $4.58 Billion
Q3 2023 Nov 26, 2024	BUY	$164.66 - $218.08 $395,184 - $523,392	2,400 Added 33.95%	9,470 $1.61 Billion
Q3 2022 Nov 26, 2024	BUY	$123.79 - $277.42 $875,195 - $1.96 Million	7,070 New	7,070 $1.59 Billion
Q2 2022 Nov 26, 2024	BUY	$93.97 - $143.33 $664,367 - $1.01 Million	7,070 New	7,070 $884 Million
Q4 2021 Nov 22, 2024	BUY	$110.64 - $159.4 $782,224 - $1.13 Million	7,070 New	7,070 $932 Million
Q2 2021 Nov 22, 2024	BUY	$107.45 - $135.95 $759,671 - $961,166	7,070 New	7,070 $787 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.